Affiliate disclosure
We earn a commission if you sign up with Found through the links on this page. It did not buy a favourable review.
Found is one of the longest-running telehealth weight-loss platforms, operating since 2019 with more than 100,000 members. Unlike most of the market it treats medication as one component rather than the whole product, bundling personalised behavioural and nutritional coaching around it, and it offers both compounded and FDA-approved brand-name options. It is aimed at people who want the behaviour-change side taken seriously. The term to understand before signing up is a $99 fee for cancelling before six months — something no other provider we have reviewed charges.
Overview
Found predates the GLP-1 boom, which shows in how it is built: personalised assessment, behavioural coaching, nutritional guidance and medication where appropriate, rather than a prescription funnel with support bolted on. Its longevity is itself a signal in a market dominated by companies incorporated in the last eighteen months.
It also offers a genuinely wide medication range spanning compounded and brand-name products, which means it can move you to an approved medicine if compounded supply tightens — a real advantage given the FDA's pending 503B decision.
Found at a Glance
| Medications offered | Compounded semaglutide and tirzepatide, plus FDA-approved Wegovy pill and pen, Zepbound and Foundayo |
|---|---|
| Brand-name or compounded | Both compounded and brand-name; the compounded products are not FDA-approved |
| Consultation process | Online assessment with personalised programme design; clinician review for prescribing |
| Eligibility | Assessed at intake; clinical criteria apply |
| Provider involvement | Clinician oversight plus behavioural and nutritional coaching included in the programme |
| Lab requirements | Used as part of the assessment where clinically indicated |
| Pharmacy fulfillment | Not named for compounded products; brand-name dispensed as manufacturer product |
| Shipping frequency | Included in the programme |
| Support services | Personalised coaching is the core of the offering, and the most praised element in reviews |
| Membership fees | Programme pricing rather than a separate membership; GLP-1 access quoted from $129/month self-pay or $49 with insurance |
| Medication fees | Compounded semaglutide from about $169/month on a 12-month plan; compounded tirzepatide from $299; Wegovy pill $149–$299; Wegovy pen $349–$399; Zepbound $299–$449; Foundayo $149–$299 |
| Cancellation policy | A $99 cancellation fee applies if you cancel before completing a six-month commitment |
| Refund policy | Not detailed beyond the cancellation fee |
| Insurance | Supported, and materially reduces cost |
| HSA/FSA | Not clearly stated |
| Availability | US; state list not published in detail |
Pricing Across Compounded and Brand-Name
| Medication | Reported monthly cost | Status |
|---|---|---|
| Compounded semaglutide | From $169 (12-month plan) | Not FDA-approved |
| Compounded tirzepatide | From $299 | Not FDA-approved |
| Wegovy pill | $149–$299 | FDA-approved |
| Wegovy pen | $349–$399 | FDA-approved |
| Zepbound | $299–$449 | FDA-approved |
Found also quotes GLP-1 access from $129 a month self-pay, or $49 with insurance. The range is wide because the product range is wide, and the structure genuinely rewards having coverage.
On level, compounded semaglutide at $169 sits mid-market — above Trimi Health at $99, comparable to RenewMD at $179 — and it comes with coaching included, which most cheaper providers do not offer at any price. The brand-name options are less competitive: NovoCare Pharmacy sells the Wegovy pen from $199 against Found's $349.
The $99 Cancellation Fee
Found charges a $99 cancellation fee to patients who cancel before completing a six-month commitment. Across everything we have reviewed on this site, no other provider charges an explicit fee simply for leaving early.
Plenty of providers make multi-month plans non-refundable, which has a clear rationale — the medication has been dispensed. A separate exit fee is different: it is a charge for the act of stopping, not for anything supplied.
There is a defensible argument for it. Found's model front-loads assessment, programme design and coaching, and a member who leaves in month two has consumed most of that cost without the revenue to cover it. Six months is also a clinically reasonable horizon for a weight-loss programme rather than an arbitrary lock-in.
But the group most likely to pay it is the group least able to predict it: people who start a GLP-1, cannot tolerate the side effects, and stop within weeks. Charging them $99 on the way out is a poor outcome. If you are new to GLP-1 medication and unsure how you will tolerate it, factor that $99 into your decision — and confirm the current terms in writing, since fee structures change.
What the Coaching Actually Adds
Found's differentiator is that behavioural and nutritional coaching is part of the programme rather than a $49.99 add-on as at Shed, and reviewers consistently single out coaches as the best part of the service.
That matters most at the end rather than the beginning. Weight regain after stopping a GLP-1 is the central problem in this category, and the behavioural habits built while on medication are what determine whether loss holds. A programme that treats coaching as core is better designed for that than one selling vials. Our maintenance guide covers why.
The honest caveat is that coaching quality varies by individual coach, and no platform-level review can tell you who you will be assigned.
Eligibility, Contraindications, and Side Effects
Found assesses eligibility at intake. See our eligibility guide for what a thorough screen should cover.
Semaglutide and tirzepatide carry a boxed warning regarding thyroid C-cell tumours, based on rodent studies. You should not take these medications if you or a family member have had medullary thyroid carcinoma, if you have Multiple Endocrine Neoplasia syndrome type 2, or if you have had a serious hypersensitivity reaction to the active ingredient. They are not for use in pregnancy. A history of pancreatitis, gallbladder disease, gastroparesis or other severe gastrointestinal disease, or diabetic retinopathy, warrants specific discussion first.
Common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation and abdominal pain — worst after a dose increase. Serious but less common risks include pancreatitis, gallbladder disease and acute kidney injury from dehydration. Our side effects guide covers management. Note the interaction with the cancellation fee: intolerance is the most common reason people stop early, and it is exactly when the $99 would apply.
How Found Compares
| Provider | Compounded semaglutide | Coaching included | Exit cost | Our rating |
|---|---|---|---|---|
| Found | $169 (annual) | Yes — core to the model | $99 before six months | 3.4 / 5 |
| WeightWatchers | Brand-name only | Yes — dietitian included | Non-refundable $49 consult | 3.8 / 5 |
| Fridays | ~$150 (annual) | Yes — bundled | None published | 3.3 / 5 |
| RNK Health | $197 | Yes — dedicated coach | None — month to month | 3.6 / 5 |
RNK Health is the closest comparison on structure — coaching included, similar price band — and it operates month-to-month with no exit fee. That is the specific thing Found asks you to accept in exchange for its longer track record and wider medication range.
Pros and Cons
Pros
- Operating since 2019 with 100,000+ members — unusually long track record
- Behavioural and nutritional coaching included, not an add-on
- Coaches are the most praised element in reviews
- Both compounded and FDA-approved brand-name options
- Can move you to approved medication if compounded supply tightens
- Insurance supported, bringing GLP-1 access to about $49/month
- Compounded semaglutide from $169 with coaching included is fair value
Cons
- $99 cancellation fee before six months — unique among providers we review
- That fee hits hardest on people who cannot tolerate the medication
- The $169 rate requires a twelve-month plan
- Brand-name pricing is uncompetitive — $349 Wegovy pen versus $199 direct
- Trustpilot only 3.6 across a modest 280-plus reviews
- Compounding pharmacy not named
- State coverage not published in detail
- Coaching quality varies by individual coach
Who Should Pick It, and Who Should Look Elsewhere
Found suits you if you want the behavioural side treated as part of the treatment rather than an upsell, you are confident you will stay at least six months, and you value a provider that has been doing this since before the GLP-1 boom. If you have insurance, the $49 access price makes the coaching effectively free.
Look elsewhere if you are trying a GLP-1 for the first time and do not yet know whether you tolerate it — the $99 exit fee turns a bad reaction into a bad bill. RNK Health includes a dedicated coach with no commitment. And if you want brand-name medication, buy it direct: NovoCare Pharmacy is substantially cheaper.
Limitations of This Review
This review is based on independent coverage including U.S. News, and review platforms, checked on 7 August 2026. Pricing varies by plan length, medication and insurance, and the figures here are reported ranges rather than a rate card we verified directly. We could not locate a BBB profile for Found. The compounding pharmacy is not named and state coverage is not published in detail. We have not signed up or been prescribed, and coaching quality is inherently individual.
Frequently Asked Questions
Does Found charge a cancellation fee?
Yes — $99 if you cancel before completing a six-month commitment. No other provider we review charges an explicit fee for leaving early. Confirm the current terms in writing before enrolling.
How much does Found cost?
GLP-1 access is quoted from $129/month self-pay or $49 with insurance. Compounded semaglutide is around $169/month on a twelve-month plan and compounded tirzepatide from $299; brand-name options run from $149 for the Wegovy pill up to $449 for Zepbound.
Is the coaching worth it?
Coaches are the most consistently praised part of Found in reviews, and behavioural support is the factor most associated with keeping weight off after medication stops. Quality varies by individual coach.
Does Found offer FDA-approved medication?
Yes. Alongside compounded semaglutide and tirzepatide it offers the FDA-approved Wegovy pill and pen, Zepbound and Foundayo — useful if compounded supply tightens.
Verdict
3.4 / 5
A long-established programme that takes behaviour change seriously and offers both compounded and approved medication — with a $99 exit fee that lands hardest on the people least able to predict they will need it.
Found is one of the more thoughtfully built services in this category. Coaching as a core component rather than an upsell is the right design for a problem that does not end when the prescription does, and having both compounded and approved medication on the shelf is genuine resilience. The reservation is a single term: charging someone $99 for stopping a medication they could not tolerate is a bad look on an otherwise decent programme, and competitors offer comparable coaching with no exit penalty at all.
Medical Disclaimer & Review Date
This review is general consumer information, not medical advice. GLP-1 medications are prescription drugs with serious contraindications, and whether any treatment is appropriate for you is a decision only a licensed healthcare provider who knows your medical history can make. Nothing here should be used to start, stop, or change a medication.
Details in this review come from Found's own published materials as of the date below. Pricing, medication availability, state coverage, and policies in this category change frequently — verify current terms directly with the provider before purchasing.
Date reviewed: August 7, 2026
Confirm the Exit Terms First
Before enrolling, get the current cancellation fee and the six-month condition in writing — particularly if this is your first GLP-1.